Skip to main navigation
About Us
Our Living Values
Senior Management
Board of Directors
Collaborations
Corporate Compliance & Ethics
Corporate Responsibility
Contact Us
Pipeline
Lorigerlimab (PD-1 × CTLA-4)
MGC026 (B7-H3 ADC)
MGC028 (ADAM9 ADC)
MGD024 (CD123 × CD3)
Technology
Platforms
CDMO Capabilities
Publications
Patients
Clinical Trials
Expanded Access
Resources
Investors
Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Senior Management
Board of Directors
Committee Composition
Contact the Board
Charters and Documents
Financials & Filings
SEC Filings
Quarterly Results
Key Metrics
Stock Information
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Ownership Profile
Investor FAQs
Publications
Contact Investor Relations
Join Our Team
Current Openings
Employee Benefits
Biography
Shareholder Tools
Facebook
LinkedIn
Twitter
RSS
Breadcrumb
Home
Investors
analyst
Robert Burns
Robert Burns
H.C. Wainwright
